| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 134, 222-228, Copyright © 1994 by Endocrine Society
ARTICLES |
S Eguchi, Y Hirata, T Imai, K Kanno and F Marumo
Second Department of Internal Medicine, Tokyo Medical and Dental University, Japan.
An endothelium-derived vasoactive peptide, endothelin (ET)-1, is a potent constrictor and mitogen for vascular smooth muscle cells (VSMC). To determine whether vascular ET receptor subtypes phenotypically change during in vitro culture conditions, we studied the expression of ET receptor subtypes, ET-induced phosphoinositide breakdown, and DNA synthesis in cultured rat VSMCs during serial passages. Binding studies using [125I]ET-1 as a radioligand revealed that the early passage (10th- 15th) VSMCs possess predominantly ETA receptors, whereas the late passage (30th-35th) VSMCs possess predominantly ETB receptors in addition to ETA receptors. Northern blot analysis using cDNAs for rat ETA and ETB receptors as probes also demonstrated the predominant expression of ETA receptor mRNA in the early passage and ETB receptor mRNA in the late passage, whereas only ETA receptor mRNA was expressed in intact medium of rat aorta. ET-1 had a greater effect than ET-3 in stimulating inositol 1,4,5-trisphosphate formation, whereas ET-1 and ET- 3 almost equipotently stimulated insitol 1,4,5-trisphosphate formation in the late passage VSMC even in the presence of an ETA receptor antagonist. ET-1-induced DNA synthesis was almost completely inhibited by an ETA receptor antagonist in the early passage VSMC. In contrast, ET-1, ET-3, and an ETB receptor agonist remarkably stimulated DNA synthesis in the late passage VSMC, which was completely inhibited by a nonselective ET receptor antagonist, but not by an ETA receptor antagonist. Our data provide the first evidence that a phenotypic change in VSMC in culture is concomitantly associated with a change in the ET receptor subtype that potentiates mitogenic activity and suggest that switching the ET receptor subtype from ETA to ETB during phenotypic change may in part contribute to the development of vascular lesions, such as in atherosclerosis.
This article has been cited by other articles:
![]() |
H. Ohtsu, S. Higuchi, H. Shirai, K. Eguchi, H. Suzuki, A. Hinoki, E. Brailoiu, A. D. Eckhart, G. D. Frank, and S. Eguchi Central Role of Gq in the Hypertrophic Signal Transduction of Angiotensin II in Vascular Smooth Muscle Cells Endocrinology, July 1, 2008; 149(7): 3569 - 3575. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Jamali and L. Edvinsson Involvement of protein kinases on the upregulation of endothelin receptors in rat basilar and mesenteric arteries. Experimental Biology and Medicine, April 1, 2006; 231(4): 403 - 411. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Breuiller-Fouche, C. Moriniere, E. Dallot, S. Oger, R. Rebourcet, D. Cabrol, and M.-J. Leroy Regulation of the Endothelin/Endothelin Receptor System by Interleukin-1{beta} in Human Myometrial Cells Endocrinology, November 1, 2005; 146(11): 4878 - 4886. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tang, Q. Hao, T. Fitzgerald, T. Sasaki, E. J. Landon, and T. Inagami Pyk2/CAKbeta Tyrosine Kinase Activity-mediated Angiogenesis of Pulmonary Vascular Endothelial Cells J. Biol. Chem., February 8, 2002; 277(7): 5441 - 5447. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. DAVIE, S. J. HALEEN, P. D. UPTON, J. M. POLAK, M. H. YACOUB, N. W. MORRELL, and J. WHARTON ETA and ETB Receptors Modulate the Proliferation of Human Pulmonary Artery Smooth Muscle Cells Am. J. Respir. Crit. Care Med., February 1, 2002; 165(3): 398 - 405. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kawanabe, Y. Okamoto, T. Enoki, N. Hashimoto, and T. Masaki Ca2+ channels activated by endothelin-1 in CHO cells expressing endothelin-A or endothelin-B receptors Am J Physiol Cell Physiol, November 1, 2001; 281(5): C1676 - C1685. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. C. Docherty, J. Kalmar-Nagy, M. Engelen, S. V. Koenen, M. Nijland, R. E. Kuc, A. P. Davenport, and P. W. Nathanielsz Effect of in vivo fetal infusion of dexamethasone at 0.75 GA on fetal ovine resistance artery responses to ET-1 Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2001; 281(1): R261 - R268. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. MELO, M. E. STEINHELPER, S. C. PANG, Y. TSE, and U. ACKERMANN ANP in regulation of arterial pressure and fluid-electrolyte balance: lessons from genetic mouse models Physiol Genomics, June 29, 2000; 3(1): 45 - 58. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tang, T. Nishishita, T. Fitzgerald, E. J. Landon, and T. Inagami Inhibition of AT1 Receptor Internalization by Concanavalin A Blocks Angiotensin II-induced ERK Activation in Vascular Smooth Muscle Cells. INVOLVEMENT OF EPIDERMAL GROWTH FACTOR RECEPTOR PROTEOLYSIS BUT NOT AT1 RECEPTOR INTERNALIZATION J. Biol. Chem., April 28, 2000; 275(18): 13420 - 13426. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Maeda, U. Ikeda, K.-i. Oya, M. Shimpo, S. Ueno, K. Okada, T. Saito, H. Mano, K. Ozawa, and K. Shimada Endogenously Generated Nitric Oxide by Nitric-Oxide Synthase Gene Transfer Inhibits Cellular Proliferation J. Pharmacol. Exp. Ther., January 1, 2000; 292(1): 387 - 393. [Abstract] [Full Text] |
||||
![]() |
S. Eguchi, H. Iwasaki, H. Ueno, G. D. Frank, E. D. Motley, K. Eguchi, F. Marumo, Y. Hirata, and T. Inagami Intracellular Signaling of Angiotensin II-induced p70 S6 Kinase Phosphorylation at Ser411 in Vascular Smooth Muscle Cells. POSSIBLE REQUIREMENT OF EPIDERMAL GROWTH FACTOR RECEPTOR, RAS, EXTRACELLULAR SIGNAL-REGULATED KINASE, AND AKT J. Biol. Chem., December 24, 1999; 274(52): 36843 - 36851. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. L. Furge, K. Chen, and S. Cohen Annexin VII and Annexin XI Are Tyrosine Phosphorylated in Peroxovanadate-treated Dogs and in Platelet-derived Growth Factor-treated Rat Vascular Smooth Muscle Cells J. Biol. Chem., November 19, 1999; 274(47): 33504 - 33509. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Eguchi, H. Iwasaki, T. Inagami, K. Numaguchi, T. Yamakawa, E. D. Motley, K. M. Owada, F. Marumo, and Y. Hirata Involvement of PYK2 in Angiotensin II Signaling of Vascular Smooth Muscle Cells Hypertension, January 1, 1999; 33(1): 201 - 206. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Mohuczy, C. H. Gelband, and M. I. Phillips Antisense Inhibition of AT1 Receptor in Vascular Smooth Muscle Cells Using Adeno-Associated Virus-Based Vector Hypertension, January 1, 1999; 33(1): 354 - 359. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. Melo, A. T. Veress, U. Ackermann, and H. Sonnenberg Chronic regulation of arterial blood pressure by ANP: role of endogenous vasoactive endothelial factors Am J Physiol Heart Circ Physiol, November 1, 1998; 275(5): H1826 - H1833. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Iwasaki, S. Eguchi, M. Shichiri, F. Marumo, and Y. Hirata Adrenomedullin as a Novel Growth-Promoting Factor for Cultured Vascular Smooth Muscle Cells: Role of Tyrosine Kinase-Mediated Mitogen-Activated Protein Kinase Activation Endocrinology, August 1, 1998; 139(8): 3432 - 3441. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Matsuura, W. Yamochi, K.-i. Hirata, S. Kawashima, and M. Yokoyama Stimulatory Interaction Between Vascular Endothelial Growth Factor and Endothelin-1 on Each Gene Expression Hypertension, July 1, 1998; 32(1): 89 - 95. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Maxwell, R. G. Goldie, and P. J. Henry Altered ETB- but not ETA-receptor density and function in sheep airway smooth muscle cells in culture Am J Physiol Lung Cell Mol Physiol, June 1, 1998; 274(6): L951 - L957. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Eguchi, K. Numaguchi, H. Iwasaki, T. Matsumoto, T. Yamakawa, H. Utsunomiya, E. D. Motley, H. Kawakatsu, K. M. Owada, Y. Hirata, et al. Calcium-dependent Epidermal Growth Factor Receptor Transactivation Mediates the Angiotensin II-induced Mitogen-activated Protein Kinase Activation in Vascular Smooth Muscle Cells J. Biol. Chem., April 10, 1998; 273(15): 8890 - 8896. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Richman and J. W. Regan alpha 2-Adrenergic receptors increase cell migration and decrease F-actin labeling in rat aortic smooth muscle cells Am J Physiol Cell Physiol, March 1, 1998; 274(3): C654 - C662. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yamakawa, S. Eguchi, Y. Yamakawa, E. D. Motley, K. Numaguchi, H. Utsunomiya, and T. Inagami Lysophosphatidylcholine Stimulates MAP Kinase Activity in Rat Vascular Smooth Muscle Cells Hypertension, January 1, 1998; 31(1): 248 - 253. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Adner, E. Uddman, L. O. Cardell, and L. Edvinsson Regional variation in appearance of vascular contractile endothelin-B receptors following organ culture Cardiovasc Res, January 1, 1998; 37(1): 254 - 262. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Eguchi, J. Nishimura, S. Kobayashi, K. Komori, K. Sugimachi, and H. Kanaide Down-regulation of endothelin B receptors in autogenous saphenous veins grafted into the arterial circulation Cardiovasc Res, August 1, 1997; 35(2): 360 - 367. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Ikeda, K. Yamamoto, Y. Maeda, M. Shimpo, T. Kanbe, and K. Shimada Endothelin-1 Inhibits Nitric Oxide Synthesis in Vascular Smooth Muscle Cells Hypertension, January 1, 1997; 29(1): 65 - 69. [Abstract] [Full Text] |
||||
![]() |
C. R. Bacon, N. R.B. Cary, and A. P. Davenport Endothelin Peptide and Receptors in Human Atherosclerotic Coronary Artery and Aorta Circ. Res., October 1, 1996; 79(4): 794 - 801. [Abstract] [Full Text] |
||||
![]() |
S. Eguchi, T. Matsumoto, E. D. Motley, H. Utsunomiya, and T. Inagami Identification of an Essential Signaling Cascade for Mitogen-activated Protein Kinase Activation by Angiotensin II in Cultured Rat Vascular Smooth Muscle Cells. POSSIBLE REQUIREMENT OF Gq-MEDIATED p21ras ACTIVATION COUPLED TO A Ca2+/CALMODULIN-SENSITIVE TYROSINE KINASE J. Biol. Chem., June 14, 1996; 271(24): 14169 - 14175. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, S. A. Douglas, C. Louden, L. M. Vickery-Clark, G. Z. Feuerstein, and E. H. Ohlstein Expression of Endothelin-1, Endothelin-3, Endothelin-Converting Enzyme-1, and Endothelin-A and Endothelin-B Receptor mRNA After Angioplasty-Induced Neointimal Formation in the Rat Circ. Res., February 1, 1996; 78(2): 322 - 328. [Abstract] [Full Text] |
||||
![]() |
Y. Hirata, H. Hayakawa, E. Suzuki, K. Kimura, K. Kikuchi, T. Nagano, M. Hirobe, and M. Omata Direct Measurements of Endothelium-Derived Nitric Oxide Release by Stimulation of Endothelin Receptors in Rat Kidney and Its Alteration in Salt-Induced Hypertension Circulation, February 15, 1995; 91(4): 1229 - 1235. [Abstract] [Full Text] |
||||
![]() |
S. Eguchi, P. J. Dempsey, G. D. Frank, E. D. Motley, and T. Inagami Activation of MAPKs by Angiotensin II in Vascular Smooth Muscle Cells. METALLOPROTEASE-DEPENDENT EGF RECEPTOR ACTIVATION IS REQUIRED FOR ACTIVATION OF ERK AND p38 MAPK BUT NOT FOR JNK J. Biol. Chem., March 9, 2001; 276(11): 7957 - 7962. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |